Proapoptosis and antiapoptosis-related molecules during postnatal pancreas development in control and nonobese diabetic mice: Relationship with innervation

Laboratory Investigation

Volumn 83, Issue 2, 2003, Pages 227-239

  Durant, Sylvie ^a   Geutskens, Sacha ^a,b   Van Blokland, Saskia C A ^b   Coulaud, Josiane ^a   Alves, Véronique ^a   Pleau, Jean Marie ^a   Versnel, Marjan ^b   Drexhage, Hemmo A ^b   Homo Delarche, Françoise ^a,c  

^a CNRS   (France)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON INDUCIBLE PROTEIN 10; PERIPHERIN; PROTEIN BCL 2;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INNERVATION; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MOUSE; MOUSE STRAIN; NEUROFILAMENT; NONHUMAN; PATHOGENESIS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN INTERACTION; STRAIN DIFFERENCE;

EID: 0037324941     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000053914.93282.A5     Document Type: Article

References (89)

1. Augstein P, Stephens LA, Allison J, Elefanty AG, Ekberg M, Kay TW, and Harrison LC (1998). Beta-cell apoptosis in an accelerated model of autoimmune diabetes. Mol Med 4:495- 501.
2. Bach JF (1994). Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516-542.
3. Bacon KB and Harrison JK (2000). Chemokines and their receptors in neurobiology: Perspectives in physiology and homeostasis. J Neuroimmunol 104:92-97.
4. Bechmann I, Mor G, Nilsen J, Eliza M, Nitsch R, and Naftolin F (1999). FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier. Glia 27:62-74.
5. Benoist C and Mathis D (1997). Cell death mediators in autoimmune diabetes: No shortage of suspects. Cell 89:1-3.
6. Boitard C, Villa MC, Becourt C, Gia HP, Huc C, Sempe P, Portier MM, and Bach JF (1992). Peripherin: An islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products. Proc Natl Acad Sci USA 89:172-176.
7. Bouwens L and De Blay E (1996). Islet morphogenesis and stem cell markers in rat pancreas. J Histochem Cytochem 44:947-951.
8. Bruck W (1997). The role of macrophages in Wallerian degeneration. Brain Pathol 7:741-752.
9. Burek MJ and Oppenheim RW (1996). Programmed cell death in the developing nervous system. Brain Pathol 6:427-446.
10. Campani D, Esposito I, Boggi U, Cecchetti D, Menicagli M, De Negri F, Colizzi L, Del Chiaro M, Mosca F, Fornaciari G, and Bevilacqua G (2001). Bcl-2 expression in pancreas development and pancreatic cancer progression. J Pathol 194:444-450.
11. Cha S, van Blockland SC, Versnel MA, Homo-Delarche F, Nagashima H, Brayer J, Peck AB, and Humphreys-Beher MG (2001). Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy. Exp Clin Immunogenet 18:143-160.
12. Charré S, Rosmalen JG, Pelegri C, Alves V, Leenen PJ, Drexhage HA, and Homo-Delarche F (2002). Abnormalities in dendritic cell and macrophage accumulation in the pancreas of nonobese diabetic mice during the early neonatal period. Histol Histopathol 17:393-401.
13. Cuadros MA, Martin C, Coltey P, Almendros A, and Navascues J (1993). First appearance, distribution, and origin of macrophages in the early development of the avian central nervous system. J Comp Neurol 330:113-129.
14. Dahlen E, Dawe K, Ohlsson L, and Hedlund G (1998). Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J Immunol 160:3585-3593.
15. Dore BA, Grogan WM, Madge GE, and Webb SR (1981). Biphasic development of the postnatal mouse pancreas. Biol Neonate 40:209-217.
16. Esch TR and Taubman MA (1998). Autoantibodies in salivary hypofunction in the NOD mouse. Ann NY Acad Sci 842:221-228.
17. Fadok VA, Bratton DL, and Henson PM (2001). Phagocyte receptors for apoptotic cells: Recognition, uptake, and consequences. J Clin Invest 108:957-962.
18. Farlie PG, Dringen R, Rees SM, Kannourakis G, and Bernard O (1995). bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci USA 92:4397-4401.
19. Finegood DT, Scaglia L, and Bonner-Weir S (1995). Dynamics of beta-cell mass in the growing rat pancreas: Estimation with a simple mathematical model. Diabetes 44:249-256.
20. Gilon P and Henquin JC (2001). Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev 22:565-604.
21. Granville DJ, Carthy CM, Hunt DW, and McManus BM (1998). Apoptosis: Molecular aspects of cell death and disease. Lab Invest 78:893-913.
22. Greeley SA, Katsumata M, Yu L, Eisenbarth GS, Moore DJ, Goodarzi H, Barker CF, Naji A, and Noorchashm H (2002). Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 8:399-402.
23. Greenlund LJ, Korsmeyer SJ, and Johnson EM Jr (1995). Role of BCL-2 in the survival and function of developing and mature sympathetic neurons. Neuron 15:649-661.
24. Griffith TS and Ferguson TA (1997). The role of FasL-induced apoptosis in immune privilege. Immunol Today 18:240-244.
25. Haanen C and Vermes I (1996). Apoptosis: Programmed cell death in fetal development. Eur J Obstet Gynecol Reprod Biol 64:129-133.
26. Hanke J (2000). Apoptosis and occurrence of Bcl-2, Bak, Bax, Fas and FasL in the developing and adult rat endocrine pancreas. Anat Embryol (Berl) 202:303-312.
27. Hesselgesser J and Horuk R (1999). Chemokine and chemokine receptor expression in the central nervous system. J Neurovirol 5:13-26.
28. Homo-Delarche F (2001). Is pancreas development abnormal in the non-obese diabetic mouse, a spontaneous model of type I diabetes? Braz J Med Biol Res 34:437-447.
29. Homo-Delarche F (1997). Beta-cell behaviour during the prediabetic stage. Part II. Non-insulin-dependent and insulin-dependent diabetes mellitus. Diabetes Metab 23:473-505.
30. Honjin H (1956). The innervation of the pancreas of the mouse, with special reference to the structure of the peripheral extension of the vegetative nervous system. J Comparative Neurol 104:331-371.
31. Hugues S, Mougneau E, Ferlin W, Jeske D, Hofman P, Homann D, Beaudoin L, Schrike C, Von Herrath M, Lehuen A, and Glaichenhaus N (2002). Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity 16:169-181.
32. Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, and Drexhage HA (1994). Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 43:667-675.
33. Kerr JF, Wyllie AH, and Currie AR (1972). Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257.
34. Kieseier BC, Krivacic K, Jung S, Pischel H, Toyka KV, Ransohoff RM, and Hartung HP (2000). Sequential expression of chemokines in experimental autoimmune neuritis. J Neuroimmunol 110:121-129.
35. Kobayashi H, Doi R, Hosotany R, Myamoto Y, Koshiba T, Fujimoto K, Ida J, Tsuji S, Nakajima H, Kawagachi M, Shiota K, and Imamura M (2000). Immunohistochemical analysis of apoptosis-related proteins in human embryonic and fetal pancreatic tissues. Int J Pancreatol 27:113-122.
36. Kuhlmann T, Bitsch A, Stadelmann C, Siebert H, and Bruck W (2001). Macrophages are eliminated from the injured peripheral nerve via local apoptosis and circulation to regional lymph nodes and the spleen. J Neurosci 21:3401-3408.
37. Kurrer MO, Pakala SV, Hanson HL, and Katz JD (1997). Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 94:213-218.
38. Kusakabe T, Matsuda H, Kawakami T, Syoui N, Kurihara K, Tsukuda M, and Takenaka T (1997). Distribution of neuropeptide-containing nerve fibers in the human submandibular gland, with special reference to the difference between serous and mucous acini. Cell Tissue Res 288:25-31.
39. Lang RA and Bishop JM (1993). Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell 74:453-462.
40. Leenen PJ, de Bruijn MF, Voerman JS, Campbell PA, and van Ewijk W (1994). Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods 174:5-19.
41. Legg PG (1968). Fluorescence studies on neural structures and endocrine cells in the pancreas of the cat. Z Zellforsch Mikrosk Anat 88:487-495.
42. Lety MA, Coulaud J, Bens M, Dardenne M, and HomoDelarche F (1992). Enhanced metabolism of arachidonic acid by macrophages from nonobese diabetic (NOD) mice. Clin Immunol Immunopathol 64:188-196.
43. Luan JJ, Monteiro RC, Sautes C, Fluteau G, Eloy L, Fridman WH, Bach JF, and Garchon HJ (1996). Defective Fc gamma RII gene expression in macrophages of NOD mice: Genetic linkage with up-regulation of IgG1 and IgG2b in serum. J Immunol 157:4707-4716.
44. Marrack P, Kappler J, and Kotzin BL (2001). Autoimmune disease: Why and where it occurs. Nat Med 7:899-905.
45. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T, and Debatin KM (1999). CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci 19:3809-3817.
46. Mevorach D, Zhou JL, Song X, and Elkon KB (1998). Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188:387-392.
47. Miyamoto Y, Hosotani R, Wada M, Lee JU, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Doi R, Kato M, Shimada Y, and Imamura M (1999). Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers. Oncology 56:73-82.
48. Moujahid A, Navascues J, Marin-Teva JL, and Cuadros MA (1996). Macrophages during avian optic nerve development: Relationship to cell death and differentiation into microglia. Anat Embryol (Berl) 193:131-144.
49. O'Brien BA, Harmon BV, Cameron DP, and Allan DJ (1997). Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 46:750-757.
50. O'Brien BA, Huang Y, Geng X, Dutz JP, and Finegood DT (2002). Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 51:2481-2488.
51. Park C, Sakamaki K, Tachibana O, Yamashima T, Yamashita J, and Yonehara S (1998). Expression of fas antigen in the normal mouse brain. Biochem Biophys Res Commun 252: 623-628.
52. Pelegri C, Rosmalen JG, Durant S, Throsby M, Alves V, Coulaud J, Esling A, Pleau JM, Drexhage HA, and HomoDelarche F (2001). Islet endocrine-cell behavior from birth onward in mice with the nonobese diabetic genetic background. Mol Med 7:311-319.
53. Perry VH and Brown MC (1992). Macrophages and nerve regeneration. Curr Opin Neurobiol 2:679-682.
54. Persson-Sjogren S (2001). Neuroinsular complex type I: Morphology and frequency in lean and genetically obese mice. Pancreas 23:40-48.
55. Petrik J, Arany E, McDonald TJ, and Hill DJ (1998). Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology 139:2994-3004.
56. Piganelli JD, Martin T, and Haskins K (1998). Splenic macrophages from the NOD mouse are defective in the ability to present antigen. Diabetes 47:1212-1218.
57. Platt N, da Silva RP, and Gordon S (1998). Recognizing death: The phagocytosis of apoptotic cells. Trends Cell Biol 8:365-372.
58. Portier MM, Escurat M, Landon F, Djabali K, and Bousquet O (1993). Peripherin and neurofilaments: Expression and role during neural development. C R Acad Sci Paris 316:1133-1140.
59. Prochazka M, Gaskins HR, Shultz LD, and Leiter EH (1992). The nonobese diabetic scid mouse: Model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci USA 89:3290-3294.
60. Radosevic K, Casteels KM, Mathieu C, Van Ewijk W, Drexhage HA, and Leenen PJ (1999). Splenic dendritic cells from the non-obese diabetic mouse induce a prolonged proliferation of syngeneic T cells: A role for an impaired apoptosis of NOD T cells? J Autoimmun 13:373-382.
61. Raoul C, Henderson CE, and Pettmann B (1999). Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J Cell Biol 147:1049-1062.
62. Rosen A and Casciola-Rosen L (2001). Clearing the way to mechanisms of autoimmunity. Nat Med 7:664-665.
63. Rosmalen JG, Homo-Delarche F, Durant S, Kap M, Leenen PJ, and Drexhage HA (2000a). Islet abnormalities associated with an early influx of dendritic cells and macrophages in NOD and NOD scid mice. Lab Invest 80:769-777.
64. Rosmalen JG, Leenen PJ, Pelegri C, Drexhage HA, and Homo-Delarche F (2002). Islet abnormalities in the pathogenesis of autoimmune diabetes. Trends Endocrinol Metab 13: 209-214.
65. Rosmalen JG, Martin T, Dobbs C, Voerman JS, Drexhage HA, Haskins K, and Leenen PJ (2000b). Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: Correlation with the development of diabetes. Lab Invest 80:23-30.
66. Sabelko-Downes KA and Russell JH (2000). The role of fas ligand in vivo as a cause and regulator of pathogenesis. Curr Opin Immunol 12:330-335.
67. Saikumar P, Dong Z, Mikhailov V, Denton M, Weinberg JM, and Venkatachalam MA (1999). Apoptosis: Definition, mechanisms, and relevance to disease. Am J Med 107:489-506.
68. Sakata K, Sakata A, Kong L, Dang H, and Talal N (1998). Role of Fas/FasL interaction in physiology and pathology: The good and the bad. Clin Immunol Immunopathol 87:1-7.
69. Saravia-Fernandez F, Faveeuw C, Blasquez-Bulant C, Tappaz M, Throsby M, Pelletier G, Vaudry H, Dardenne M, and Homo-Delarche F (1996). Localization of gammaaminobutyric acid and glutamic acid decarboxylase in the pancreas of the nonobese diabetic mouse. Endocrinology 137:3497-3506.
70. Scaglia L, Cahill CJ, Finegood DT, and Bonner-Weir S (1997). Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138:1736-1741.
71. Serizawa Y, Kobayashi S, and Fujita T (1979). Neuro-insular complex type I in the mouse: Re-evaluation of the pancreatic islet as a modified ganglion. Arch Histol Jpn 42:389-394.
72. Serreze DV, Gaskins HR, and Leiter EH (1993). Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 150:2534-2543.
73. Sharma K, Wang RX, Zhang LY, Yin DL, Luo XY, Solomon JC, Jiang RF, Markos K, Davidson W, Scott DW, and Shi YF (2000). Death the Fas way: Regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther 88:333-347.
74. Siegel RM, Chan FK, Chun HJ, and Lenardo MJ (2000). The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 1:469-474.
75. Signore A, Annovazzi A, Gradini R, Liddi R, and Ruberti G (1998). Fas and Fas ligand-mediated apoptosis and its role in autoimmune diabetes. Diabetes Metab Rev 14:197-206.
76. Signore A, Annovazzi A, Procaccini E, Beales PE, Spencer J, Testi R, and Ruberti G (1997). CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice. Diabetologia 40:1476-1479.
77. Sorenson RL, Garry DG, and Brelje TC (1991). Structural and functional considerations of GABA in islets of Langerhans: Beta-cells and nerves. Diabetes 40:1365-1374.
78. Sunami E, Kanazawa H, Hashizume H, Takeda M, Hatakeyama K, and Ushiki T (2001). Morphological characteristics of Schwann cells in the islets of Langerhans of the murine pancreas. Arch Histol Cytol 64:191-201.
79. Teitelman G, Guz Y, Ivkovic S, and Ehrlich M (1998). Islet injury induces neurotrophin expression in pancreatic cells and reactive gliosis of peri-islet Schwann cells. J Neurobiol 34:304-318.
80. Thomas HE, Darwiche R, Corbett JA, and Kay TW (1999). Evidence that beta cell death in the nonobese diabetic mouse is Fas independent. J Immunol 163:1562-1569.
81. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, and McDevitt HO (1993). Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72-75.
82. Trudeau JD, Dutz JP, Arany E, Hill DJ, Fieldus WE, and Finegood DT (2000). Neonatal beta-cell apoptosis: A trigger for autoimmune diabetes? Diabetes 49:1-7.
83. van Blokland SC, van Helden-Meeuwsen CG, Wierenga-Wolf AF, Drexhage HA, Hooijkaas H, van de Merwe JP, and Versnel MA (2000). Two different types of sialoadenitis in the NOD- and MRL/Ipr mouse models for Sjögren's syndrome: A differential role for dendritic cells in the initiation of sialoadenitis? Lab Invest 80:575-585.
84. Vaux DL and Korsmeyer SJ (1999). Cell death in development. Cell 96:245-254.
85. Wada M, Doi R, Hosotani R, Lee JU, Fujimoto K, Koshiba T, Miyamoto Y, Fukuoka S, and Imamura M (1997). Expression of Bcl-2 and PCNA in duct cells after pancreatic duct ligation in rats. Pancreas 15:176-182.
86. Wang X, Ellison JA, Siren AL, Lysko PG, Yue TL, Barone FC, Shatzman A, and Feuerstein GZ (1998). Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat. J Neurochem 71:1194-1204.
87. Winer S, Astsaturov I, Cheung R, Gunaratnam L, Kubiak V, Cortez MA, Moscarello M, O'Connor PW, McKerlie C, Becker DJ, and Dosch HM (2001a). Type I diabetes and multiple sclerosis patients target islet plus central nervous system autoantigens: Nonimmunized nonobese diabetic mice can develop autoimmune encephalitis. J Immunol 166:2831-2841.
88. Winer S, Astsaturov I, Cheung RK, Schrade K, Gunaratnam L, Wood DD, Moscarello MA, O'Connor P, McKerlie C, Becker DJ, and Dosch HM (2001b). T cells of multiple sclerosis patients target a common environmental peptide that causes encephalitis in mice. J Immunol 166:4751-4756.
89. Wohlleben G, Ibrahim SM, Schmidt J, Toyka KV, Hartung HP, and Gold R (2000). Regulation of Fas and FasL expression on rat Schwann cells. Glia 30:373-381.